Medical Imaging Corporation (TPEX:6637)
56.00
+1.60 (2.94%)
Oct 8, 2026, 1:21 PM CST
Medical Imaging Revenue
Medical Imaging had revenue of 330.90M TWD in the quarter ending June 30, 2026, a decrease of -48.64%. This brings the company's revenue in the last twelve months to 915.34M, down -24.93% year-over-year. In the year 2025, Medical Imaging had annual revenue of 1.16B with 40.45% growth. That makes Medical Imaging the 31,611th largest company in the world by revenue and 1,619th in Taiwan.
Revenue (ttm)
915.34M
Revenue Growth
-24.93%
P/S Ratio
1.64
Revenue / Employee
21.79M
Employees
42
Market Cap
1.50B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.16B | 335.35M | 40.45% |
| Dec 31, 2024 | 829.03M | 146.84M | 21.53% |
| Dec 31, 2023 | 682.18M | 194.89M | 40.00% |
| Dec 31, 2022 | 487.29M | -116.83M | -19.34% |
| Dec 31, 2021 | 604.12M | 58.20M | 10.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 20.75B |
| AViTA | 972.61M |
| Sunny Pharmtech | 233.36M |
| Taiwan Biomaterial | 182.32M |
| Caliway Biopharmaceuticals | 29.39M |
| Heron Neutron Medical | 11.69M |
| Great Novel Therapeutics Biotech & Medicals | 6.21M |